Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asynchronous Messaging Therapy for Depression and Anxiety: A Longitudinal Study

NCT03699488 is registered in ClinicalTrials.gov with Talkspace as lead sponsor.

NCT NCT03699488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03699488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asynchronous Messaging Therapy for Depression and Anxiety: A Longitudinal Study
Lead sponsor
Talkspace
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
February 1, 2018
Enrollment
12,980 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, depressive symptoms